Colorectal Cancer

Latest News

FIT | Image credit: Paul Maguire - stock.adobe.com
Commercial FIT Capable of Similar Diagnostic Results as New Stool DNA Test

November 19th 2024

Lowering the positivity threshold for a high-quality fecal immunochemical test (FIT) can increase sensitivity of noninvasive screening for colorectal cancer in a more economical way.

Colorectal cancer | Image credit: Dr_Microbe - stock.adobe.com
Smoking a Risk Factor for CRC in Black African Patients

November 11th 2024

CRC | Image credit: mi_viri - stock.adobe.com
Disparities Persist in CRC Screening, Management Between High-, Low-Income Countries

November 7th 2024

Colorectal cancer | Image credit: Sebastian Kaulitzki - stock.adobe.com
Overall, Progression-Free Survival in Colon Cancer Indicated Through Visceral Proteins

November 5th 2024

Jeffrey Reese Contributor
Contributor: An Urgent Call to Action as Colorectal Cancer Rates Skyrocket Among Young People

November 4th 2024

More News

Black woman in hospital | Image credit: N F/peopleimages.com - stock.adobe.com
February 8th 2024

Non-White Patients With CRC Have Increased Odds of Emergent Resection

Julia Bonavitacola
Emergent colorectal cancer (CRC) resection was found to be more prevalent in patients who identified as non-White.
Colorectal Cancer | Image credit: mi_viri - stock.adobe.com
February 5th 2024

Rectal Surgery, Male Sex Risk Factors for Anastomotic Leakage

Julia Bonavitacola
Several risk factors put patients with colorectal cancer at increased risk of anastomotic leakage after elective surgery.
Colorectal Cancer | Image credit: Dr_Microbe - stock.adobe.com
February 1st 2024

Telehealth, e-Health Psychological Interventions Potentially Promote Sexual Health in CRC

Julia Bonavitacola
Patients with colorectal cancer (CRC) could participate in telehealth and e-health interventions to promote their sexual health, although efficacy of these interventions needs to be further studied.
Adult measuring waist | Image credit: BillionPhotos.com - stock.adobe.com
January 18th 2024

Causal Relationship Found Between Obesity in Metabolic Syndrome and CRC

Julia Bonavitacola
Obesity related to metabolic syndrome was found to have a causal relationship with colorectal cancer (CRC), although this causal relationship did not exist in the opposite direction.
Woman in headscarf | Image credit: Africa Studio - stock.adobe.com
January 17th 2024

American Cancer Society Report Estimates Higher Cancer Incidence in 2024

Julia Bonavitacola
Incidence of colorectal cancer is expected to rise in both male and female patients aged 50 years and younger.
Doctor displaying human intestine | Image credit: mi_viri - stock.adobe.com
January 16th 2024

POSSUM, Other Scoring Systems Unable to Estimate Perioperative Complications in CRC

Julia Bonavitacola
Mortality and morbidity in patients with colorectal cancer (CRC) cannot be accurately predicted using the Physiological and Operative Severity Score for the enumeration of Mortality and Morbidity (POSSUM) in the present day.
Colorectal Cancer | Image Credit: SciePro - stock.adobe.com
January 9th 2024

Risk of Colorectal Cancer Higher in Patients With Chronic Kidney Disease

Julia Bonavitacola
Patients with chronic kidney disease are at a higher risk of developing any stage of colorectal cancer.
Probiotic bottle | Image credit: Aleksandra Gigowska - stock.adobe.com
January 5th 2024

Probiotics Prevent Surgical Site Infections in Patients With CRC

Julia Bonavitacola
Patients with colorectal cancer (CRC) undergoing operations were able to prevent postoperative infections and shorten hospital stays by taking probiotics beforehand.
Intestines | Image credit: mi_viri - stock.adobe.com
January 3rd 2024

Least Differentiation Analysis Reliably Measures LNM Risk in Submucosal Invasive CRC

Julia Bonavitacola
Tumor grading via least differentiation analysis was found to be a way to measure the risk of lymph node metastasis (LNM) in patients with submucosal invasive colorectal cancer (CRC).
Top 5 Most-Read Colorectal Cancer Articles of 2023
December 30th 2023

Top 5 Most-Read Colorectal Cancer Articles of 2023

Julia Bonavitacola
The topics included clinical staging of colorectal cancer, FDA approvals, and a study published in the print version of the American Journal of Managed Care®.
Doctor holding illustration of intestine | Image credit: mi_viri - stock.adobe.com
December 21st 2023

Preventing Prolonged Ileus, Anastomotic Leaks Could Reduce Readmissions in CRC

Julia Bonavitacola
Patients with colorectal cancer (CRC) had reduced readmissions when treatment focused on preventing prolonged ileus, increasing the use of minimally invasive surgery, and preventing anastomotic leaks.
Colorectal cancer | Image credit: Dr_Microbe - stock.adobe.com
December 18th 2023

Adjuvant Chemotherapy Could Improve Prognosis in Patients With CRC

Julia Bonavitacola
Patients aged 80 years and older with colorectal cancer (CRC) could have an improved prognosis at the completion of adjuvant chemotherapy.
Chemotherapy Toxicities in Nonmetastatic CRC Associated With Low Skeletal Muscle
December 14th 2023

Chemotherapy Toxicities in Nonmetastatic CRC Associated With Low Skeletal Muscle

Julia Bonavitacola
Skeletal muscle proved to be significant in calculating chemotherapy toxicities in nonmetastatic colorectal cancer (CRC).
Colorectal cancer screening | Image credit: © Orawan - stock.adobe.com
December 12th 2023

Perforation Not Necessarily Poor Prognostic Factor in Patients With Metastatic CRC

Julia Bonavitacola
Patients with metastatic colorectal cancer (CRC) who experience colon perforation may have similar survival times to those without perforation.
Colon Cancer | Image credit: SciePro - stock.adobe.com
December 12th 2023

Novel Comprehensive Blood Indicator Potential Prognostic Factor for CRC

Julia Bonavitacola
Predicting clinical outcomes in patients with colorectal cancer (CRC) could be done using the novel comprehensive blood indicator PSI.
Incidence of CRC Increased in Male Patients Younger Than 50 Years
December 7th 2023

Incidence of CRC Increased in Male Patients Younger Than 50 Years

Julia Bonavitacola
Although the incidence of colorectal cancer (CRC) decreased in individuals older than 50 years, incidence of CRC increased in male individuals younger than 50 years.
Potential Link Exists Between Constipation, Colorectal Cancer
December 5th 2023

Potential Link Exists Between Constipation, Colorectal Cancer

Julia Bonavitacola
A Mendelian randomization found that a potential link between constipation and colorectal cancer, with support for constipation as a cause of colorectal cancer.
Aesthetic handdrawn highlighted illustration of human intestine | Image credit: mi_viri - stock.adobe.com
November 27th 2023

Screening Associated With Overall Survival After Metachronous Metastasis in CRC

Julia Bonavitacola
Patients with colorectal cancer (CRC) who had diagnosed metachronous metastasis had longer overall survival when the primary tumor was detected through screening.
Dark blue ribbon for colon - colorectal cancer awareness on medical doctor's hand support | Image credit: Chinnapong - stock.adobe.com
November 21st 2023

FIT Screening Found to Be Unsatisfactory in 10% of Submitted Tests

Julia Bonavitacola
More than 10% of fecal immunochemical test (FIT)–based colorectal cancer screening could not be processed due to unsatisfactory samples.
Unrecognizable female doctor holding graphic virtual visualization model of Intestine organ in hands | Image credit: mi_viri - stock.adobe.com
November 13th 2023

28-Day Mortality Predicted by Machine Learning in Patients With CRC

Julia Bonavitacola
Critically ill older patients with colorectal cancer (CRC) had their 28-day mortality predicted using machine learning algorithms.
Mailed Stool Tests Increased CRC Screening in Systemwide Program
November 10th 2023

Mailed Stool Tests Increased CRC Screening in Systemwide Program

Julia Bonavitacola
The implementation of a mailed stool test program increased colorectal cancer (CRC) screen-up-to-date rates compared with lower-intensity interventions, such as patient letters.
FDA Approved | Image credit: Olivier Le Moal - stock.adobe.com.jpg
November 9th 2023

FDA Approves Fruquintinib for Metastatic Colorectal Cancer

Gina Mauro
The FDA has approved fruquintinib (Fruzaqla) for the treatment of adult patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.
Higher Rate of Metastasis to Main Nodes in Transverse Colon Cancer
November 7th 2023

Higher Rate of Metastasis to Main Nodes in Transverse Colon Cancer

Julia Bonavitacola
Caecal cancer and ascending colon cancer had slower rates of metastasis to main nodes compared with transverse colon cancer.
Postoperative ctDNA Status May Prognosticate DFS Outcomes in Resected CRC
November 3rd 2023

Postoperative ctDNA Status May Prognosticate DFS Outcomes in Resected CRC

Courtney Flaherty
Postoperative circulating tumor DNA (ctDNA)–based minimal residual disease status demonstrated prognostic value for patients with stage 1 to 4 resected colorectal cancer, showing that those with positive ctDNA after surgery have significantly lower disease-free survival outcomes at 24 months vs those who were ctDNA negative.
Aesthetic handdrawn highlighted illustration of human intestine | Image credit: mi_viri - stock.adobe.com
November 1st 2023

Inflammatory Markers Have Prognostic Value in Patients With CRC

Julia Bonavitacola
Patients with colorectal cancer (CRC) can use C-reactive protein (CRP), lymphocyte to CRP ratio, and CRP to albumin ratio as markers for CRC prognosis.
Patients With High BMI, Diabetes Had Higher Risk of Infection After Colorectal Surgery
October 27th 2023

Patients With High BMI, Diabetes Had Higher Risk of Infection After Colorectal Surgery

Julia Bonavitacola
Patients who underwent surgery for colorectal cancer had a higher risk of postoperative infection if they had high body mass index (BMI) or diabetes, among other risk factors.
Metabolic Dysregulation Could Contribute to Incidence of Colorectal Serrated Lesions
October 24th 2023

Metabolic Dysregulation Could Contribute to Incidence of Colorectal Serrated Lesions

Julia Bonavitacola
The incidence of colorectal serrated lesions could be attributed to metabolic syndrome, which causes metabolic dysregulation.
FDA Approves RAS Mutation Detection Kit as Companion Diagnostic for Panitumumab in mCRC
October 20th 2023

FDA Approves RAS Mutation Detection Kit as Companion Diagnostic for Panitumumab in mCRC

Chris Ryan
The FDA has approved the CRCdx RAS Mutation Detection Kit as a companion diagnostic for panitumumab in the treatment of patients with metastatic colorectal cancer (mCRC), according to an announcement from EntroGen.
Webinar Highlights Recommendations to Improve Disparities in CRC Screening
October 18th 2023

Webinar Highlights Recommendations to Improve Disparities in CRC Screening

Julia Bonavitacola
Experts in colorectal cancer (CRC) discussed the new health recommendations from the Network for Excellence in Health Innovations report and how they apply to the disparities in screening for CRC.
Clinical Staging of Colorectal Cancer Increased in Post–COVID-19 Period
October 12th 2023

Clinical Staging of Colorectal Cancer Increased in Post–COVID-19 Period

Julia Bonavitacola
Significant increases in clinical staging for colorectal cancer were found when evaluating the extended timeframes beyond pre– and post–COVID-19 periods.
<12345>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo